Similar Articles
521 Severe digital ischemia coexists with thrombocytopenia in malignancy-associated antiphospholipid syndrome: A case report and review of literature
522 Surgery for hepatocellular carcinoma with tumor thrombosis in inferior vena cava: A case report
523 Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
524 Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
525 Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
526 Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
527 Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma
528 Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy
529 Anatomic resection improved the long-term outcome of hepatocellular carcinoma patients with microvascular invasion: A prospective cohort study
530 Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA